Diplomat supports patients nationwide who receive intravenous inhibitors of tumor necrosis factor (TNF)-alpha for inflammatory conditions. These include Remicade® (infliximab), Simponi Aria® (golimumab), and biosimilars of infliximab.

TNF-alpha is a protein that helps the body regulate its immune system. Too much can lead to inflammatory diseases such as Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

Intravenous TNF-alpha inhibitors can reduce inflammation and stop disease progression, relieving patients’ sometimes life-altering symptoms.

Diplomat is committed to breaking down barriers to care—including providing home administration of intravenous TNF-alpha inhibitors, securing third-party financial assistance, and working on prior authorizations and appeals. We are here for patients 24/7, ready to answer clinical questions and offer support. We do whatever it takes to help patients manage their therapy.

Resources

  • Financial Assistance

    Financial Assistance

    We help connect patients with nonprofit, manufacturer-sponsored and third-party funding options to keep therapy affordable.
  • Ask a Nurse

    Ask a Nurse

    Drop us a line. We can help answer your questions about therapy, side effects, and more.
  • Can I Use Diplomat?

    Can I Use Diplomat?

    We provide benefits investigation and help verify your eligibility for our programs and services. Fill out a simple form and we’ll get in touch with you.

Take the first step in partnering with us.

Twitter